Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 2.

Journal Article

Kvasnicka, H. M., Thiele, J., Bueso-Ramos, C. E., Sun, W., Cortes, J., Kantarjian, H. M. and Verstovsek, S. (2014). CHANGES IN BONE MARROW MORPHOLOGY IN PATIENTS WITH MYELOFIBROSIS TREATED FOR UP TO 5 YEARS WITH EITHER RUXOLITINIB OR BEST AVAILABLE THERAPY. Haematologica, 99. S. 127 - 129. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078

Stelljes, M., Kreuzer, K. -A, Deangelo, D. J., Advani, A. S., Goekbuget, N., Liedtke, M., Stock, W., Martinelli, G., O'Brien, S., Wang, K., Wang, T., Paccagnella, M. L., Sleight, B., Vandendries, E., Jabbour, E. J. and Kantarjian, H. M. (2016). Inotuzumab ozogamicin (InO) for relapsed/refractory (r/r) acute lymphoblastic leukemia (ALL) in the global phase 3 randomized controlled ino-vate trial: efficacy and safety by age and prior therapy. Oncol. Res. Treat., 39. S. 201 - 203. BASEL: KARGER. ISSN 2296-5262

This list was generated on Thu Mar 28 14:53:12 2024 CET.